Serendipitous synergism – an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature

Immune checkpoint inhibitors (ICIs) are the current guideline recommended treatment for many malignancies considered to be terminal. Despite considerable advances, their utility remains limited, and the field requires synergistic partners to further improve outcomes. Oncolytic viruses (OV) are emerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoury, Lara M., Burcher, Kimberly M., Ng, Ronald T., Song, Alexander H., Chang, Mark J., Gavrila, Elena, Bloomer, Chance H., Robinson, Mac B., Kouri, Brian E., Waltonen, Joshua D., Bunch, Paul M., Lauer, Ulrich M., Porosnicu, Mercedes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597005/
https://www.ncbi.nlm.nih.gov/pubmed/36312814
http://dx.doi.org/10.1177/17588359221122729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597005/
https://www.ncbi.nlm.nih.gov/pubmed/36312814
http://dx.doi.org/10.1177/17588359221122729

Ejemplares similares